{
  "hash": "84ff58a02173c33b14472b1e708ca124",
  "result": {
    "markdown": "---\ntitle: \"Prospectus\"\ndate-modified: today\ndate-format: medium\nauthor:\n  - name: \"Sicheng Wang\"\n    email: Wangs22@wfu.edu\n    affiliation: \"Wake Forest University\"\nabstract: |\n  Biotechnology sectors have been favored by investors in recent years, but biomedical texts often contain specialized jargon and abbreviations, making them difficult to read. Previous studies on biomedical literature translation mainly targeted biomedical experts, neglecting those without such background. This paper adopts a reader-based translation approach guided by Skopos theory, which aims to translate a text for a specific purpose. As a case study, this paper translates a Nature article “Control of the Activity of CAR-T Cells within Tumors via Focused Ultrasound” from English to Chinese, targeting investors without biomedical expertise. Utilizing Wordfast to ensure accuracy, especially in translating field-specific terms, and abbreviations, this study summarizes and examines translation options to aid non-biomedical investors’ understanding. Based on Hyland's metadiscourse markers, which writers employ to aid readers' comprehension, this paper uses RStudio to count markers utilized in translation, serving as an indicator of our attempts to assist readers’ comprehension. This study serves as a starting point for exploring translation options of biomedical literature for investors without a biomedical background. To bolster these translation options’ practicability, it is suggested to expand the corpus and incorporate feedback from readers.\nkeywords:\n  - metadiscourse marker\n  - biomedical literacture translation\n  - reader-oriented\n  - Skopos theory\n  - E-C\ncitation: true\nbibliography: \"../bibliography.bib\"\nformat:\n  html: default\n  pdf:\n    number-sections: true\n---\n\n\n# Introduction\n\nAgainst the backdrop of normalized epidemic prevention and control and supported initiatives such as the “Healthy China Initiative,” the urgency and significance of China’s biopharmaceutical industry development have surged [@Sun2022]. Frost & Sullivan reported that the Chinese biopharmaceutical market ranks among the most promising in the global pharmaceutical domain. Venture capital investment has increasingly focused on the biotechnology and healthcare sectors over the past five years [@Fan2021]. Yet, the scarcity of professionals with dual expertise in biomedicine and financial investment stifles innovation in biopharmaceutical firms. Biomedical texts often contain normalization sentences loaded with specialized jargon and abbreviations [@Tian2022], posing challenges for translation [@Zhao2005]. According to @reiss1981type, biomedical texts are considered informative, primarily focused on conveying information. Previous studies have targeted biomedical texts as informative text types for translation analysis, such as @Zhang2023, who analyzed biomedical texts based on the characteristics of informative texts guard by communicative translation theory [@newmark1981approaches]. However,  biomedical texts could also be viewed as operative texts. @Ding2016 summarized translation options based on text function theory [@newmark1988textbook], suggesting that technical texts could also be seen as operative texts. The emphasis on discussing translation options in biomedical texts as informative text types is attributed to the target readers, which primarily comprises scholars, experts, and individuals in the biomedical field [@Tan2020; @Li2012; @Zheng2020]. Few studies focus on readers lacking a biomedical background. @Wang2022 targeted investors without biomedical expertise, while @Wang2020 focused on the general public, and @Pei2017 targeted customers. However, this focus is primarily on genres such as news and prescriptions. There is a gap in research focusing on readers without a biomedical background in biomedical literature. This paper aims to fill this gap by focusing on investors lacking biomedical expertise, summarizing translation options for biomedical literature through the translation of a paper published in Nature titled “Control of the Activity of CAR-T Cells within Tumours via Focused Ultrasound [@wu2021control]” from English to Chinese.  The selected portion includes 3,128 words in total. The choice of this paper is driven by Acoustic Cell Therapy Inc.’s initiative, planning to commence Phase III clinical trials in China and seeking Chinese investors [@Acoustic]. Given the reader-oriented focus of this paper, Skopos theory is used as a guiding framework, aiming to translate a text for a specific purpose and target readers in a particular setting [@du2012brief]. To showcase the efficacy of the translation methods used in this paper for enhancing readers’ understanding, Hyland's metadiscourse markers [@hyland2004metadiscourse] are utilized as a benchmark. According to @Hyland2018, metadiscourse facilitates smooth communication, improves text readability, and fosters reader engagement. Earlier studies revealed that metadiscourse bolsters the propositional content of discourse and enhances its readability [@shi2014research]. @hyland2004metadiscourse emphasized that metadiscourse serves as a bridge between text and readers. @hyland2004disciplinary categorizes metadiscourse into two main types: interactive and interactional. Interactive metadiscourse guides readers through the text based on the writer's interpretations. Interactional metadiscourse, on the other hand, involves the writer more directly in conveying information to the readers. Interactive resources encompass various elements such as transitions (establishing relationships between sentences), frame markers (structuring sequences), endophoric markers (referring to information within the text), evidentials (citing other authorities), and code glosses (rephrasing for clarity). Interactional resources include hedges (introducing vagueness), boosters (emphasizing), attitude markers (indicating the writer's stance), engagement markers (drawing the reader's attention), and self-mentions (references to the author themselves). For translating technical jargon, we suggest to use amplification, whether it involves adding explanations directly into the text or clarifying the meaning of jargon by translating its full name. If adding explanations directly results in an overload of particles, inserting them into brackets then, to prevent disruption of the reading flow. However, for jargon with functions already explained in the source text, additional explanations are unnecessary. For jargon that appear more than twice, we suggest to provide explanations only the first time. For abbreviations, we choose to either replace them or provide explanations. Abbreviations created solely for the convenience of a single paper’s writing are replaced, while those widely used in the biomedical field have explanations added right after them. Borrowing is another option used for biomedical abbreviations' translation. According to @Liu1998, biomedical literature in China features numerous borrowed words, as modern medicine was introduced from abroad after the 18th century. Unified translations have not been established for frequently introduced terms, and English jargon abbreviations are often easier to remember than their Chinese equivalents. For long sentences, splitting them and identifying the main information are recommended. We can highlight the main idea instead of overwhelming the reader with excessive details.\n\n## Research problem\nBiomedical literature translation methods targeting on layperson especially investors.\n\n## Research questions\nIs the number of metadiscourse markers greater in the target text than in the source text?\n\n## Research objectives\nIn order to suggest the translation methods used in the source text potentially facilitates readers' comprehension.\n\n## Expected impact\nAn initial exploration of biomedical literature translation methods for individuals lacking a biomedical background.\n\n# Literature review\n1. @herriman2014metadiscourse compared the metadiscourse markers of English and Swedish in non-fiction texts and their translations. She discovered that transition markers increased in translation samples, reflecting translators' efforts to clarify the texts. Boosters, however, were diminished when translating from Swedish into English. Her analysis relied on metadiscourse markers' frequency and p-values calculated by the Sigil Corpus Frequency Test Wizard to highlight differences in metadiscourse markers between English and Swedish non-fiction texts and their translations.\n\n2. @chou2023representation investigated the disparities between translated and non-translated English texts concerning interactional metadiscourse markers. They analyzed the Freiburg-LOB Corpus of British English and the Corpus of Chinese-English, obtaining frequency scores of metadiscourse markers via the Authorial Voice Analyzer. Their findings revealed that translated texts use fewer hedges, boosters, and attitude markers.\n\n3. @davtalab2012contrastive focused on selected texts from an academic book to examine the contrast between metadiscourse markers in English and Persian. They utilized Anova tests and t-tests to identify significant differences between the metadiscourse markers in both languages. Their analysis concluded that there is no significant difference in metadiscourse markers between English and Persian. \n\n# Methods\n\n*  The work flow:\n\n![Procedure](work_flow.png)\n\n*  The ideal data should be: \n\n\n::: {.cell}\n\n```{.r .cell-code}\nlibrary(tibble) # creating tibble\n\nidealized_tbl <- tibble(\n  category = c(\"hedges\", \"boosters\", \"attitude marker\", \"engagement markers\", \"self-mentions\", \"transitions\", \"frame markers\", \"endophoric markers\", \"code glosses\"),\n  num_EN = c(\"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\"),\n  num_CN = c(\"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\", \"*\")\n)\n\nidealized_tbl\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 9 × 3\n  category           num_EN num_CN\n  <chr>              <chr>  <chr> \n1 hedges             *      *     \n2 boosters           *      *     \n3 attitude marker    *      *     \n4 engagement markers *      *     \n5 self-mentions      *      *     \n6 transitions        *      *     \n7 frame markers      *      *     \n8 endophoric markers *      *     \n9 code glosses       *      *     \n```\n:::\n:::\n\n\nI have both the translated text and the source text, and I intend to read them into R for storage in `.csv` format. \n\n\n::: {.cell}\n\n```{.r .cell-code}\nST_txt <-\nread.csv(\"data/derived/CAR_ST_curated.csv\")\n\nTT_txt <- read.csv(\"data/derived/CAR_TT_curated.csv\")\n\nST_txt\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n    sentence_id   type\n1             1 Source\n2             2 Source\n3             3 Source\n4             4 Source\n5             5 Source\n6             6 Source\n7             7 Source\n8             8 Source\n9             9 Source\n10           10 Source\n11           11 Source\n12           12 Source\n13           13 Source\n14           14 Source\n15           15 Source\n16           16 Source\n17           17 Source\n18           18 Source\n19           19 Source\n20           20 Source\n21           21 Source\n22           22 Source\n23           23 Source\n24           24 Source\n25           25 Source\n26           26 Source\n27           27 Source\n28           28 Source\n29           29 Source\n30           30 Source\n31           31 Source\n32           32 Source\n33           33 Source\n34           34 Source\n35           35 Source\n36           36 Source\n37           37 Source\n38           38 Source\n39           39 Source\n40           40 Source\n41           41 Source\n42           42 Source\n43           43 Source\n44           44 Source\n45           45 Source\n46           46 Source\n47           47 Source\n48           48 Source\n49           49 Source\n50           50 Source\n51           51 Source\n52           52 Source\n53           53 Source\n54           54 Source\n55           55 Source\n56           56 Source\n57           57 Source\n58           58 Source\n59           59 Source\n60           60 Source\n61           61 Source\n62           62 Source\n63           63 Source\n64           64 Source\n65           65 Source\n66           66 Source\n67           67 Source\n68           68 Source\n69           69 Source\n70           70 Source\n71           71 Source\n72           72 Source\n73           73 Source\n74           74 Source\n75           75 Source\n76           76 Source\n77           77 Source\n78           78 Source\n79           79 Source\n80           80 Source\n81           81 Source\n82           82 Source\n83           83 Source\n84           84 Source\n85           85 Source\n86           86 Source\n87           87 Source\n88           88 Source\n89           89 Source\n90           90 Source\n91           91 Source\n92           92 Source\n93           93 Source\n94           94 Source\n95           95 Source\n96           96 Source\n97           97 Source\n98           98 Source\n99           99 Source\n100         100 Source\n101         101 Source\n102         102 Source\n103         103 Source\n104         104 Source\n105         105 Source\n106         106 Source\n107         107 Source\n108         108 Source\n109         109 Source\n110         110 Source\n111         111 Source\n112         112 Source\n113         113 Source\n114         114 Source\n                                                                                                                                                                                                                                                                                                                                                                                               lines\n1                                                                                                                                                                                                                                                                                                                       Control of the activity of CAR-T cells within tumours via focused ultrasound\n2                                                                                                                                                                                               Yiqian Wu , Yahan Liu, Ziliang Huang, Xin Wang, Zhen Jin, Jiayi Li, Praopim Limsakul, Linshan Zhu, Molly Allen, Yijia Pan, Robert Bussell, Aaron Jacobson, Thomas Liu, Shu Chien , and Yingxiao Wang\n3                                                                                                                                                                                                                                                                                             Focused ultrasound can deliver energy safely and non-invasively into tissues at depths of centimetres.\n4                                                                                                    Here we show that the genetics and cellular functions of chimeric antigen receptor T cells (CAR-T cells) within tumours can be reversibly controlled by the heat generated by short pulses of focused ultrasound via a CAR cassette under the control of a promoter for the heat-shock protein.\n5                                                                                   In mice with subcutaneous tumours, locally injected T cells with the inducible CAR and activated via focused ultra-sound guided by magnetic resonance imaging mitigated on-target off-tumour activity and enhanced the suppression of tumour growth, compared with the performance of non-inducible CAR-T cells.\n6                                                                                                                                                                                                                                                                                  Acoustogenetic control of the activation of engineered T cells may facilitate the design of safer cell therapies.\n7                                                                                                                                                                                                                                                      Optogenetics enables the control of specific molecular events and cellular functions in living systems with high spatio-temporal resolutions.\n8                                                                                                                                                                                                                                                         However, optogenetics cannot reach deep tissues, with the penetration depth of light typically limited at micrometre to millimetre scales.\n9                                                                                                                                                                                                                                      Ultrasound can be focused to deliver mechanical energy safely and non-invasively into small volumes of tissue deep inside the body up to tens of centimetres.\n10                                                                                                                                                                                                              The rapidly oscillating pressure of focused ultrasound (FUS) waves and the resultant cycles of mechanical loading/unloading can lead to local heat generation in biological tissues.\n11                                                                                                                                                                                             Aided by magnetic resonance imaging (MRI) thermometry, FUS has been widely applied clinically to ablate tumours and to control drug delivery, vasodilation, neuromodulation and transgene expression.\n12                                                                                                                                                                                                                             Transcription factors and genetic circuits have also been engineered to convert the FUS-generated heat into genetic regulation to control micro-bial systems in vivo.\n13                                                                                                                                                                                                                                                                   However, there is a lack of general methods using FUS to control mammalian cell functions in vivo for therapeutic applications.\n14                                                                                                                                                        Chimeric antigen receptor (CAR) T-cell therapy, where T cells are genetically programmed with redirected specificity against malignant cells, is becoming a paradigm-shifting approach for cancer treatment, especially for blood cancers.\n15                                                                                                                                                                                                                                                                                          However, major challenges remain for solid tumours before CAR-based immunotherapy can be widely adopted.\n16                                                                                                                                               For instance, the non-specific targeting of the CAR-T cells against normal tissues (on-target off-tumour toxicities) can be life-threatening: off-tumour toxicities against the lung, the brain and the heart have caused multiple cases of deaths.\n17                                                                                                                              Immunosuppressive corticosteroid therapy and suicide-gene engineering are relatively effective in suppressing off-tumour toxicities and related cytokine release syndrome, but they fail to discriminate between beneficial T-cell functions and toxic side effects.\n18                                                                                                                                        Synthetic biology and elegant genetic circuits have been used to enhance specificity and reduce off-tumour toxicity by creating chemically inducible dimerization of split CARs, inhibitory CARs and synthetic Notch (SynNotch) to control CAR activation.\n19                                                                                                            However, given the extensive overlaps of antigens between solid tumours and normal tissues, especially those under conditions of tissue injury/inflammation, it remains very difficult to identify ideal antigens and their combinations to differentiate tumours from normal tissues.\n20                                                                                                                                                                                                                                                                 There is thus an urgent need for high-precision control of CAR-T cells to confine the activation at local sites of solid tumours.\n21                                                                                                                                                                                                       Recently, we demonstrated that ultrasound signals can be amplified by microbubbles coupled to cells engineered with the mechanosensor Piezo1 to precisely control CAR- T-cell activation22.\n22                                                                                                                                                                                                                                                                                              However, the presence of micro- bubbles as cofactors limits the application of this system in vivo. \n23                                                                                                                                                                                                                                            Here we have engineered a class of inducible CAR-T cells that can be acoustogenetically and directly controlled by FUS without any exogenous cofactor.\n24                                                                                                                                                                                                   We show that short-pulsed FUS stimulation can activate the engineered T cells at the desired time and location to suppress tumour growth in vivo with greater safety than standard CAR-T cells.\n25                                                                                                                                                                                                                                                                                                                                                                                           Results\n26                                                                                                                                                                                                                                                                                                                                                            Heat-induced reporter gene activation.\n27                                                                                                                                               We propose to genetically engineer T cells with inducible CAR cassettes that can be remotely and directly activated without any exogenous cofactor, by MRI-guided FUS at local tumour sites for recognizing and eradicating tumour cells (Fig. 1a).\n28                                                                                                                                                                                                                                                                           We first tested the inducible activation of a reporter eGFP under the control of the heat-shock-protein promoter (Hsp).\n29                                                                                                                                                                                                                        We assembled a dual-promoter reporter construct containing the Hsp-driven eGFP and a constitutive mouse phosphoglycerate kinase 1 promoter (PGK)-driven mCherry (Fig. 1b).\n30                                                                                                                                                                                                                                                                                      HEK293 T cells infected with the reporter lentivirus (Supplementary Fig. 1a) were heated at 43°C for 15 min.\n31                                                                                                                                                                                Real-time fluorescence imaging revealed that the heat-induced eGFP expression started as early as 2h after heat shock (HS) and persisted throughout the course of observation (Fig. 1c and Supplementary Video 1).\n32                                                             Quantitative tracking of the dynamics of heat-induced eGFP expression by flow cytometry showed that an average of 97% of the cells expressed eGFP at 6h post HS, and the percentage increased to 99% at 12h and remained stable for 2 d, while the mean fluorescence intensity peaked at 12h followed by a steady decrease (Fig. 1d).\n33                                                                                                                                                                                                                                                         We then investigated the inducible effect of HS in primary human T cells hosting the dual-promoter eGFP reporter (Supplementary Fig. 1b).\n34                                                                                                                                                                                                                                  A 15min HS induced an eGFP expression in an average of 93% of the engineered T cells, in contrast to a background of 4% in control cells without HS (Fig. 1e,f).\n35                                                                                                                                                                                                                                                                 The mean fluorescence intensity of the eGFP+ cells in the HS group was tenfold of that in the control group without HS (Fig. 1g).\n36                                                                                                                                                                                                                                                                                                            Heat-induced CAR expression and its functionality in Jurkat and primary human T cells.\n37                                                                                                                                                                                                           To convert the transient heat stimulation to sustained gene activation and cellular functions for therapeutic actions, we integrated the Cre–lox gene switch into the inducible system.\n38                                                                                      The design is composed of two constructs, one containing the Hsp-driven Cre recombinase and the PGK-driven membrane c-Myc tag for cell sorting (‘inducible Cre’, Fig. 2a), and the other containing a lox-flanked ZsGreen-STOP sequence between PGK and an anti-CD19 CAR (‘lox-stop CAR reporter’, Fig. 2a).\n39                                                                                                                                                                                                                   As such, the excision of the STOP cassette mediated by the transiently expressed heat-induced Cre can cause a switch from ZsGreen expression to a sustained CD19CAR production.\n40                                                                                                                                                                                                                                                                                                                       We first tested this system in Jurkat T-cell lines (Supplementary Fig. 2a).\n41                                                                                        A 15min HS induced CAR expression in an average of 77% of the cells when measured 24h after HS (day 1), in contrast to an average basal level of 14% in control cells without HS and a minimal leakage of 0.6% in cells infected with the lox-stop CAR reporter alone (Fig. 2b and Supplementary Fig. 2b).\n42                                                                                                                                                                                                                                                                            The heat-induced CAR expression remained stable when measured 6 d after HS (day 6, Fig. 2b and Supplementary Fig. 2b).\n43                                                                                                                                                                                                                                                                                                   We further examined the functionality of the induced CD19CAR in the engineered cells (Fig. 2c).\n44                                                                                                                                                                                                                                                                    Engineered Jurkat cells with HS or without (CT, control) HS were co-cultured with CD19-expressing Nalm-6 tumour cells for 24h.\n45                                                                                                                                                 Quantification of the expression level of CD69 (an early T-cell activation marker) revealed an average of 71% CD69+ cell population in the engineered Jurkat cells in the HS group, in contrast to an average of 14% in the CT group (Fig. 2d,e).\n46                                                                                                                                                                                                                                                                             These results indicate that the HS-induced CD19CAR is efficient for functional changes in engineered Jurkat T cells. \n47                                                                                                                                                                                                                                                                                                       We then examined our system in primary human T cells (Fig. 2a,c and Supplementary Fig. 2c).\n48                                                                                                                                                                                                                                                 Antibody staining showed that a 15min HS induced CAR expression in 29% of the T cells, in contrast to 1.9% in control cells without HS (Fig. 2f).\n49                                                                                                                                                                                                                The heat-inducible CAR-T cells were then co-cultured with firefly luciferase (Fluc)-expressing Nalm-6 cells at different effector-to-target (E:T) ratios for cyto-toxicity assays.\n50                                                                                                                                                                                                                                                                                                            The luminescence of the remaining Nalm-6 cells was quantified after a 24 h co-culture.\n51                                                                                                   The heat-stimulated T cells (HS) demonstrated increased cytotoxicity with increased E:T ratio, with the largest contrast in cytotoxicity being observed between the HS and the control (CT) T cells at E:T=1:5, eliminating 82.9% and 29.3% of the target tumour cells, respectively (Fig. 2g).\n52                                                                                                                                       The heat-stimulated CAR-T cells also secreted substantially higher concentrations of cytokines interferon-γ (IFN-γ) and interleukin-2 (IL-2) than the control cells (Fig. 2h,i), verifying the functional capability gained by the HS-induced CAR-T cells. \n53                                                                                                                                                                                                                                                                                      While the continuous 15min HS led to strong gene inductions (Figs. 1 and 2), it may cause toxicity to cells.\n54                                                                                                                                                                                                                                                                                    We therefore investigated the effect of different HS patterns in primary human T cells (Supplementary Fig. 3).\n55                                                                                                                                   Our results showed that longer HS resulted in more cell death; however, pulsed HS was able to alleviate this toxicity while achieving induction levels comparable to that in response to continuous HS with the same total heating time (Supplementary Fig. 3).\n56                                                                                                 In particular, a pulsed HS with 50% duty cycle and a total heating time of 15min (Supplementary Fig. 3a, pattern 2) caused a strong induction of eGFP expression in 91.4% of the engineered T cells with minimal toxicity (92.2% cell viability) measured 24h after HS (Supplementary Fig. 3b–d).\n57                                                                                                                                                                                                                                                                                         Therefore, we applied this HS pattern (Supplementary Fig. 3a, pattern 2) for in vivo therapeutic studies.\n58                                                                                                                                                                                                                                                                                                                                    MRI-guided FUS-induced gene activation in phantom and in vivo.\n59                                                                                                                                                                                                   MRI-guided FUS enables the delivery of thermal energy in vivo at confined local regions with high spatiotemporal resolutions. We integrated a FUS system with a 7T MRI as described in Methods.\n60                                                                                                                                                                                                                                                                        An annular array transducer was placed above the target region of the object (phantoms or small animals) in the MRI bore. \n61  MR images were acquired and transferred to Thermoguide software to calculate the temperature of the target region in real time; this temperature was then fed back to the proportional-integral-derivative controller to automatically regulate the output power of the FUS generator, maintaining the temperature of the target region at the desired level (Fig. 3a and Supplementary Fig. 4).\n62                                                                                                                                              We transduced Nalm-6 cells with a lentiviral dual-luciferase reporter containing inducible Fluc and constitutive Rluc (Hsp–Fluc–PGK–Rluc–mCherry; Rluc, Renilla luciferase; Fig. 3b) and embedded the cells in a tofu phantom (Fig. 3c and Methods).\n63                                                                                                                                                                                                                                                                                           We then focused the ultrasound on the embedded cells by changing the focal distance in the z direction.\n64                                                                                                                                                                                                                 Three pulses of 5min FUS stimulations caused a significant induction of gene expression as quantified by the Fluc/Rluc ratio of the cells assayed 8h later (Fig. 3d and Methods).\n65                                                                                                                                         The induction level was comparable to that of the positive control using a thermal cycler with the same heating pattern (Fig. 3d), suggesting that this approach can acoustogenetically control gene activation in engineered cells with high efficiency.\n66                                                                                                                                                                           We then used MRI-guided FUS to control local temperature in vivo (Fig. 3e,f and Supplementary Video 2) and tested the FUS-induced gene activation using Nalm-6 cells with the dual-luciferase reporter in vivo in mice.\n67                                                                                                                                                               Significant gene induction was observed in the injected cells with only two pulses of 5min FUS stimulation (FUS+, after), compared with the basal level (FUS+, before) and the control groups (FUS–, before and after) (Fig. 3g,h).\n68                                                                                                                                                                                                                                                                                                                                 FUS-inducible cytotoxicity of the engineered CAR-T cells in vivo.\n69                                                                                                                                                                           To test the cytotoxicity of the FUS-inducible CAR (FUS-CAR) T cells in vivo, we subcutaneously injected Fluc+ Nalm-6 cells on both sides of NOD scid gamma (NSG) mice to generate matched bilateral tumours (Fig. 4a). \n70                                                                                                                                                                                Four days later, engineered CD19CAR T cells were injected subcutaneously at both tumour sites locally, followed by three pulses of 5min FUS stimulation at 43°C on the left but not on the right tumour (Fig. 4a).\n71                                                                                                                                                                                             Our results showed that the growth of the left tumour was significantly suppressed compared with that of the right tumour, demonstrating the in vivo cytotoxicity of the FUS-CAR-T cells (Fig. 4b,c).\n72                                                                                                                                                                                                            We included a control group where bilateral-tumour-bearing mice received FUS stimulation on one side, with neither site subjected to the injection of T cells (Supplementary Fig. 5a).\n73                                                                                                                                                                                                               The tumours on both sides exhibited similar growth profiles, indicating that FUS itself (with the chosen pattern) had negligible impact on tumour growth (Supplementary Fig. 5b,c).\n74                                                                                                                                                  An additional control where bilateral-tumour-bearing mice received local injections of naive T cells on both tumours followed by FUS stimulation on the left tumour also showed similar growth profiles of both tumours (Supplementary Fig. 6). \n75                                                                                                                                                                                                                                           Therefore, our results demonstrated that FUS can be used to precisely control the cyto-toxicity of FUS-CAR-T cells in vivo against target tumour cells.\n76                                                                                                                                                                                                                                                    To further validate the effectiveness of our technology, we examined the cytotoxicity of the FUS-CAR-T cells against more established tumours.\n77                                                                                                                                                                                                                                                                                     We subcutaneously injected Fluc+ Nalm-6 cells on the left side of NSG mice to generate a single tumour model.\n78                                                                                                                                                                                                                                                                      Ten days after tumour challenge, FUS-CAR-T cells were locally injected at the tumour site and activated by FUS stimulation. \n79                                                                                                                                                                                                                                                                           The control group received an injection of naive T cells followed by the same FUS stimulation (Extended Data Fig. 1a). \n80                                                                                                                                                                                                            FUS-CAR-T cells significantly suppressed tumour growth compared with the control, showing the efficacy of FUS-CAR-T-cell therapy in treating larger tumours (Extended Data Fig. 1b–d).\n81                                                                                                                                                                                                                                               Moreover, we tested this acoustogenetic technology in controlling inducible CAR-T cells against other types of tumours, particularly solid tumours.\n82                                                                                                                                                   We engineered human prostate cancer PC3 cells to express the prostate-specific membrane antigen (PSMA) and Fluc, and engineered primary human T cells with the Cre–lox mediated FUS-inducible anti-PSMA CAR (PSMACAR; Extended Data Fig. 2a,b).\n83                                                                                                                                                                                                                  We verified the functionality of the FUS-inducible PSMACAR T cells through in vitro co-culture cytotoxicity assays and the associated cytokine assays (Extended Data Fig. 2c,e).\n84                                                                                                                                                                                                   We then generated matched bilateral subcutaneous PC3 tumours (PSMA+, Fluc+) in NSG mice; five days later we subcutaneously injected FUS-inducible PSMACAR T cells locally at both tumour sites.\n85                                                                                                                                        The tumour region on the left side was treated with three pulses of 5min FUS, while that on the right remained unstimulated. Consistently, the tumours with FUS stimulation showed significantly inhibited growth compared with the controls (Fig. 4d,e). \n86                                                                                                                                                                                                                              We further collected the tumour tissues on the last day of monitoring (day 22, 17 d after FUS stimulation; Methods) and quantified the related messenger RNA amount.\n87                                                                                                                                                                                    CD3 mRNA in the FUS-treated tumours averaged threefold of that in the untreated ones, indicating more T-cell infiltration and/or expansion in the FUS-treated solid prostate tumours (Supplementary Fig. 7a). \n88                                                                                                  Moreover, the amount of Cre-mediated recombined CAR mRNA in the FUS-treated tumours was ninefold of that in the untreated controls, verifying the FUS-induced DNA recombination and subsequent CAR expression in the engineered T cells at the tumour sites (Supplementary Fig. 7 and Methods). \n89                                                                                           Additionally, in a mock control where the bilateral PC3 tumour-bearing mice received local injections of naive T cells on both tumours followed by FUS stimulation only on the left tumour, no significant difference in growth between the left and right tumours was observed (Supplementary Fig. 8).\n90                                                                                                                                                                                                    These results demonstrate the efficacy of FUS-based acoustogenetics in the control of CAR-T cells for treating different types of tumours in vivo, including solid tumours of prostate cancer.\n91                                                                                                                                                                                                                                                                                                                                                                 Safety of FUS-CAR-T-cell therapy.\n92                                                                                                                                                                                                                                                         We hypothesized that FUS-CAR-T cells have less on-target off-tumour toxicity than standard CAR-T cells with constitutive CAR expression. \n93                                                                                                                         To test this, we adopted the above-mentioned bilateral Nalm-6 tumour model and treated the tumour on one side (the proximal tumour) with a local injection of the same number of standard CD19CAR T (Supplementary Fig. 9 and Methods) or FUS-inducible CD19CAR T cells. \n94                                                                                                                                                                                                                                                           The distal tumour was used to mimic normal tissues expressing the target antigen and received no treatment (Supplementary Fig. 10a,b). \n95                                                                                                                                                                                                                                 Standard CAR-T cells not only eliminated the proximal tumour but also attacked the normal-tissue-mimicking distal tumour (Fig. 5a,b and Supplementary Fig. 10c). \n96                                                                                                                                                                                                               In contrast, FUS-CAR-T cells, after FUS activation, dramatically inhibited the growth of the proximal tumour, but spared the distal tumour (Fig. 5c,d and Supplementary Fig. 10d). \n97                                                                                                                                              Using tumour growth in control mice (with bilateral tumours, without T-cell treatment; Extended Data Fig. 3) as reference, we quantified the in vivo cyto-toxicity of the standard CAR and FUS-CAR-T cells on the last day of monitoring (Methods). \n98                                                                                                                               Standard CAR-T cells demonstrated 100% and 99.8% cytotoxicity against proximal and distal tumours, respectively; FUS-CAR-T cells showed comparable effectiveness of 95.7% against proximal tumours, but merely 9.8% effectiveness against distal tumours (Fig. 5e).\n99                                                                                                                                                                                                                                           These results suggest that FUS-CAR-T-cell therapy is safer, with significantly less on-target off-tumour toxicity than the standard CAR-T-cell therapy.\n100                                                                                                                                                                                                                                                                                                                               Developing a clinically compatible and reversible FUS-CAR-T cell. \n101                                                     To minimize the usage of exogenous components in our technology for higher clinical compatibility, we further characterized a FUS-CAR-T cell where CAR expression was directly driven by Hsp (Hsp-CAR) without the Cre–lox switch, with PGK-driven mCherry as an indicator of gene delivery efficiency (Fig. 6a and Supplementary Fig. 11a).\n102                                                                              The FUS-CAR-T cell containing Hsp-CAR represents a reversible system: CAR expression reached an average of 43.9% in primary Hsp-CAR-T cells 6h after the first HS (43°C, 15min), which dwindled down to 10.5% at 12h and returned to a basal level comparable to that of the untreated control by 24h (Fig. 6b,c). \n103                                                                                                                                                                            When treated with a second HS (43°C, 15min), we observed CAR expression in an average of 44.2% of cells, followed by the same degradation dynamics (Fig. 6c), indicating the reversible nature of the Hsp-CAR system.\n104                                                                                                                                                                       We examined the functionality of the reversible FUS-CAR-T cells using the cytotoxicity assay as described above, and observed stronger cytotoxicity of the FUS-CAR cells with HS activation than those without (Fig. 6d). \n105                                                                                                                                                                                         The largest contrast was seen at an E:T ratio of 1:5, with the activated reversible FUS-CAR-T cells eliminating 83% of tumour cells compared with the 36% elimination by the control T cells (Fig. 6d). \n106                                                                                                                                                                                                                                                                                                                              The specific killing was verified by cytokine secretions (Fig. 6e).\n107                                                                                                                                                                                                                                                              To investigate the performance of the reversible FUS-CAR-T cells in vivo, we generated bilateral Fluc+ Nalm-6 tumours in NSG mice. \n108                                                                                                                                                                                              The tumour on one side (proximal tumour) received a local injection and FUS activation of the reversible FUS-CAR-T cells; this treatment was repeated on day 4 and day 7 (Supplementary Fig. 11b). \n109                                                                                                                                                                                                                                                                                                                                          The contralateral distal tumour received no treatment. \n110                                                                                                                                                           Our results showed that the growth of the proximal tumour was drastically inhibited compared with that of the distal tumour (Fig. 6f,g), demonstrating sufficient efficacy and minimal side effect of the reversible FUS-CAR-T cells. \n111                                                             In a control group where the proximal tumour was repeatedly stimulated by FUS on day 4 and day 7 but without T-cell administration, the proximal tumour demonstrated similar aggressiveness as the distal tumour, suggesting that the repeated FUS stimulation itself had no direct effect on tumour growth (Extended Data Fig. 4). \n112                                                                                                                                                                                                  We also included a control group where the proximal tumour received local injections of the reversible FUS-CAR-T cells on day 4 and day 7 but without FUS stimulation (Extended Data Fig. 5a). \n113                                                                                                                                                         While the growth of the proximal tumour slightly slowed down, probably due to basal CAR expressions and allogeneic responses of the T cells, it still demonstrated an average of 1,318-fold growth by day 24 (Extended Data Fig. 5b,c). \n114                                                                                                                                                                                                             Taken together, our results demonstrate the reversibility, efficacy and safety of the reversible FUS-CAR-T cells that minimized the use of clinically untested exogenous components.\n```\n:::\n\n```{.r .cell-code}\nTT_txt\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n    sentence_id   type\n1             1 Target\n2             2 Target\n3             3 Target\n4             4 Target\n5             5 Target\n6             6 Target\n7             7 Target\n8             8 Target\n9             9 Target\n10           10 Target\n11           11 Target\n12           12 Target\n13           13 Target\n14           14 Target\n15           15 Target\n16           16 Target\n17           17 Target\n18           18 Target\n19           19 Target\n20           20 Target\n21           21 Target\n22           22 Target\n23           23 Target\n24           24 Target\n25           25 Target\n26           26 Target\n27           27 Target\n28           28 Target\n29           29 Target\n30           30 Target\n31           31 Target\n32           32 Target\n33           33 Target\n34           34 Target\n35           35 Target\n36           36 Target\n37           37 Target\n38           38 Target\n39           39 Target\n40           40 Target\n41           41 Target\n42           42 Target\n43           43 Target\n44           44 Target\n45           45 Target\n46           46 Target\n47           47 Target\n48           48 Target\n49           49 Target\n50           50 Target\n51           51 Target\n52           52 Target\n53           53 Target\n54           54 Target\n55           55 Target\n56           56 Target\n57           57 Target\n58           58 Target\n59           59 Target\n60           60 Target\n61           61 Target\n62           62 Target\n63           63 Target\n64           64 Target\n65           65 Target\n66           66 Target\n67           67 Target\n68           68 Target\n69           69 Target\n70           70 Target\n71           71 Target\n72           72 Target\n73           73 Target\n74           74 Target\n75           75 Target\n76           76 Target\n77           77 Target\n78           78 Target\n79           79 Target\n80           80 Target\n81           81 Target\n82           82 Target\n83           83 Target\n84           84 Target\n85           85 Target\n86           86 Target\n87           87 Target\n88           88 Target\n89           89 Target\n90           90 Target\n91           91 Target\n92           92 Target\n93           93 Target\n94           94 Target\n95           95 Target\n96           96 Target\n97           97 Target\n98           98 Target\n99           99 Target\n100         100 Target\n101         101 Target\n102         102 Target\n103         103 Target\n104         104 Target\n105         105 Target\n106         106 Target\n107         107 Target\n108         108 Target\n109         109 Target\n110         110 Target\n111         111 Target\n112         112 Target\n113         113 Target\n114         114 Target\n115         115 Target\n116         116 Target\n117         117 Target\n118         118 Target\n119         119 Target\n120         120 Target\n121         121 Target\n122         122 Target\n123         123 Target\n124         124 Target\n125         125 Target\n126         126 Target\n127         127 Target\n128         128 Target\n129         129 Target\n130         130 Target\n131         131 Target\n132         132 Target\n133         133 Target\n134         134 Target\n135         135 Target\n136         136 Target\n137         137 Target\n138         138 Target\n139         139 Target\n140         140 Target\n141         141 Target\n142         142 Target\n143         143 Target\n                                                                                                                                                                                                                                                               lines\n1                                                                                                                                                                                                                            肿瘤治疗：聚焦超声技术精准调控CAR-T细胞\n2                                                               Yiqian Wu , Yahan Liu, Ziliang Huang, Xin Wang, Zhen Jin, Jiayi Li, Praopim Limsakul, Linshan Zhu, Molly Allen, Yijia Pan, Robert Bussell, Aaron Jacobson, Thomas Liu, Shu Chien , and Yingxiao Wang\n3                                                                                                                                                                                             聚焦超声技术，安全且无创，其超声波可作用于人体深层组织，皮下几厘米内。\n4                                                                                                                     我们的研究发现，利用CAR（一种嵌合抗原受体）基因盒，聚焦超声技术的短脉冲所产生的热能可以调控肿瘤内CAR-T细胞的基因表达和细胞功能，且具有可逆性。\n5                                                                                                                                                                                         我们通过热休克蛋白的启动因子调控CAR基因盒，从而实现CAR-T细胞的可逆性表达。\n6                                                                                                                      我们利用磁共振成像技术引导聚焦超声波激活局部注射的带有可诱导CAR的T细胞，缓解带有皮下肿瘤小鼠的非肿瘤靶向毒性，即CAR-T细胞对正常组织进行杀伤。\n7                                                                                                                                                                                                         同正常的CAR-T细胞相比，这种CAR-T细胞能有效抑制肿瘤的生长。\n8                                                                                                                                                                                                  利用超声波基因表达技术激活改造后的T细胞有望实现更安全的细胞疗法。\n9                                                                                                                                                                       光遗传学能够以高时空分辨率，捕捉清晰的微观变化，其针对生物体内的特定分子活动，调控细胞功能。\n10                                                                                                                                                                                                            但光遗传学不适用于深层组织，其穿透度在微米到毫米之间。\n11                                                                                                                                                                                        超声波可以将机械能定点传递到体内的微小组织，安全且无创，深度可达数十厘米。\n12                                                                                                                                                  聚焦超声波的高频振动，会产生一个压力，从而引起机械载荷，即物体表面受力，也会引起机械卸载，即物体表面没有受到力。\n13                                                                                                                                                                                                                      如此反复，导致生物组织中的受力区域温度升高。\n14                                                                                                                                                    借助磁共振成像测温的聚焦超声技术已经广泛应用于临床，用于消除肿瘤，药物递送，舒张血管，神经调控以及转基因表达。\n15                                                                                                                                                                  通过改造转录因子和基因回路，使得聚焦超声产生的热能用来进行基因调控，以调控生物体内的微生物系统。\n16                                                                                                                                                                              然而，目前在实际治疗中，不存在利用聚焦超声技术在体内调控哺乳动物细胞功能的通用方法。\n17                                                                                                                                                                                          CAR-T细胞疗法的基本原理是将T细胞进行基因编程，重新定向，使其针对癌细胞。\n18                                                                                                                                                                                                     CAR-T细胞疗法有望开创癌症治疗的新时代，尤其是在血癌治疗方面。\n19                                                                                                                                                               然而，在将其广泛投入市场使用前，基于CAR技术的免疫疗法仍有尚未解决的几大难题，尤其是对实体瘤的治疗。\n20                                                                                                                                                                                                     已有多起死亡案例，是由于CAR-T细胞误击人的肺部、脑部以及心脏。\n21                                                                                                                                                 由于CAR-T细胞的非特异性靶向，不会定向作用于异常细胞，导致其攻击正常组织，即出现非肿瘤靶向毒性，严重时会危及生命。\n22                                                                                                                       免疫抑制性皮质类固醇治疗和自杀基因工程在一定程度上能避免CAR-T细胞攻击正常组织和与之类似的细胞因子释放综合征，即免疫细胞分泌蛋白过多的情况。\n23                                                                                                                                                                                                      但这两种治疗方法无法单单剔除T细胞的副作用，保留T细胞的优势。\n24                                                                                                                                                                   合成生物学和基因回路已被用来增强CAR-T细胞的定向性，减轻非肿瘤靶向毒性，降低攻击正常组织的几率。\n25                                                                                                                                    其通过合成一个可化学诱导的二聚化split CAR，即双靶点激活的CAR，以及一个抑制性的CAR和SynNotch，一种人工合成受体来控制CAR的激活。\n26                                                                                                                                                                                        但还是难以找到一个理想的抗原，或是多个抗原的组合，用以区分肿瘤和正常组织。\n27                                                                                                                                                                                因为许多抗原同时存在于实体瘤和正常组织的表面，如果组织损伤或发炎了，更是难以区分。\n28                                                                                                                                                                                      因此，我们迫切需要对CAR-T细胞进行精准调控，将激活的CAR-T细胞限制在实体瘤内。\n29                                                                                                                                                                这是我们最新的发现： 利用超声信号同携带机械感应蛋白Piezo1的细胞一起，可以精确调控CAR-T细胞的激活。\n30                                                                                                                                                                                                                            利用超声微泡更是可以大大增强超声信号。\n31                                                                                                                                                                                                              但若利用超声微泡进行辅助，该方法将无法应用于人体内。\n32                                                                                                                                         所以我们进一步设计出了一类可以通过超声波进行基因调控，聚焦超声技术直接控制，且无需借助任何外部辅助因子的可诱导CAR-T细胞。\n33                                                                                                                                                         在聚焦超声的短脉冲刺激下，改造后的T细胞可以在一定的时间和范围内进行激活，更加安全地抑制肿瘤在体内的生长。\n34                                                                                                                                                                                                                                                              成果\n35                                                                                                                                                                                                                      激活受热诱导的报告基因，该基因表达易于检测。\n36                                                                                                                                             我们通过改造T细胞，引入可诱导的CAR基因盒，使CAR既能远程，又能直接激活，无需任何外部辅助因子，就能识别和清除肿瘤细胞。\n37                                                                                                                                                                                                 我们通过磁共振成像技术引导聚焦超声激活肿瘤内的CAR（见图1中的a）。\n38                                                                                                                                                                      1. 利用Hsp热休克蛋白启动因子调控可诱导激活的报告蛋白eGFP增强型绿色荧光蛋白的表达，进行检测。\n39                                                                                                                                                                                                                  首先，我们构建了一个有双启动因子的报告基因结构。\n40                                                                                                                         其中包含受Hsp热休克蛋白启动因子调控的eGFP增强型绿色荧光蛋白和一个受组成型表达小鼠的PGK酶启动因子调控的红色荧光染料mCherry（见图1中的b）。\n41                                                                                                                                                                                                                      组成型表达小鼠的启动因子后直接接着目的基因。\n42                                                                                                                                                                        我们将被慢病毒报告基因感染的HEK293 T胚胎肾细胞（见附录图1中的a）加热到43°C，热处理15分钟。\n43                                                                                                                              实时荧光成像显示，受热诱导的eGFP增强型绿色荧光蛋白在受热2小时后就开始表达，整个观察过程中，该蛋白持续表达（见图1中的c和附录视频1）。\n44                                                                                               通过流式细胞仪实时量化追踪受热诱导的eGFP增强型绿色荧光蛋白的表达，结果显示，平均97%的细胞在受热6小时后发出绿色荧光； 12小时后，这一比例增至99%，且稳定表达2天时间。\n45                                                                                                                                                                                            平均荧光强度在受热12小时后达到峰值，随后呈平稳下降趋势（见图1中的d）。\n46                                                                                                                                                                                                 我们随后对原代人的T细胞的受热诱导情况进行检测（见附录图1中的b）。\n47                                                                                                                                                                                               该原代人的T细胞携带具有双启动因子的eGFP增强型绿色荧光蛋白报告基因。\n48                                                                                                                                 热刺激15分钟后，平均93%的改造后的T细胞呈现绿色荧光，相比之下，未受热处理的对照组荧光表达率为4%，且见于染色背景（见图1中的e和f）。\n49                                                                                                                                                                            实验组中，表达eGFP增强型绿色荧光蛋白的细胞的平均荧光强度是对照组的十倍（见图1中的g）。\n50                                                                                                                                                                                                 2. Jurkat T淋巴细胞和原代人的T细胞中受热诱导的CAR的表达及其作用。\n51                                                                                                                           为了使基因持续保持激活状态，细胞功能持续表达，以实现治疗的目的，我们将Cre-lox基因开关整合到诱导模型中，从而无需一直依赖于热刺激的作用。\n52                                                                                                                                                                                                                                              该模型由两部分组成。\n53                                                                                                                                                                                   第一部分由受到Hsp热休克蛋白启动因子调控的Cre重组酶以及受PGK酶调控的细胞膜组成。\n54                                                                                                                                                                                其中的细胞膜用c-Myc标签蛋白进行标记，以便筛选细胞（如图2中的a所示的可诱导的Cre）。\n55                                                                             第二部分由携带了PGK酶和抗CD19（B淋巴细胞上的抗体）CAR的DNA片段组成，酶和DNA片段中间还插入了一段序列，即lox-ZsGreen荧光蛋白-STOP终止序列-lox（如图2中的a所示的lox-stop CAR报告基因）。\n56                                                                                                                                                                 通过激活受热诱导的Cre重组酶，切除STOP序列，使得原先的ZsGreen荧光蛋白不表达，含CD19抗体的CAR表达。\n57                                                                                                                                                                                                                     这样一来，CD19CAR的表达不再受到热刺激的限制。\n58                                                                                                                                                                                                    我们先是在Jurkat T淋巴细胞系中检测这个模型（见附录图2中的a）。\n59      实验第1天，加热诱导CAR表达，热刺激15分钟，CAR的平均表达率在受热24小时后为77%，未受热处理的对照组的平均表达率只有14%，可作为CAR一般情况下的表达率，只携带lox-stop CAR报告基因的细胞表达率为0.6%，因为少量细胞未受诱导却发生表达（见图2中的b和附录图2中的b）。\n60                                                                                                                                                                                                    实验第6天，受热诱导的CAR表达稳定（见图2中的b和附录图2中的b）。\n61                                                                                                                                                                                           我们进一步检测了改造细胞中可诱导的含CD19抗体的CAR的活性（见图2中的c）。\n62                                                                                                                                                     改造后的Jurkat T淋巴细胞经过热刺激与未受热的对照组以及表达CD19抗体的Nalm-6人的B淋巴白血病细胞共同培养24小时。\n63                                                                                                        通过对CD69抗体，早期T细胞活化标志物表达水平的量化分析，实验组中，改造后的Jurkat T淋巴细胞中的CD69抗体平均表达率为71％，而对照组仅为14％（见图2中的d和e）。\n64                                                                                                                                                                                     结果表明，受热诱导的含CD19抗体的CAR有效改变了改造后的Jurkat T淋巴细胞的功能。\n65                                                                                                                                                                                              我们同样也在原代T细胞中测试了该模型（见图2中的a，c和附录图2中的c）。\n66                                                                                                                                      通过抗体染色技术显示，15分钟的热刺激，诱导29%的T细胞表达了CAR，而未受热诱导的对照组仅有1.9%的T细胞发生了表达（见图2中的f）。\n67                                                                           随后，我们将可受热诱导的CAR-T细胞与效靶比即效应细胞（免疫细胞）和靶细胞（目标细胞）比例不同，但都表达Fluc萤火虫荧光素酶的Nalm-6肿瘤细胞共同培养，以进行细胞毒性测试，测试细胞杀伤情况。\n68                                                                                                                                                                                               T细胞和肿瘤细胞共同培养24小时后，检测剩余Nalm-6肿瘤细胞的荧光强度。\n69                                                                                         我们发现，受热刺激的T细胞毒性随着效靶比的增加而增加，当效靶比为1:5时，实验组和对照组中的T细胞毒性相差最大，实验组的目标肿瘤消除率为82.9%，对照组仅有29.3%（见图2中的g）。\n70                                                                        同对照组相比，受热刺激的CAR-T细胞同时大量分泌了干扰素-γ，一种细胞因子，以干扰病毒复制和白细胞介素-2，以促进T细胞增殖（见图2中的h及i），这大大证实了受热诱导的CAR-T细胞用于肿瘤治疗的潜力。\n71                                                                                                                                                                                  虽然15分钟的热刺激可以有效诱导基因表达（见图1和图2），但是可能会对细胞产生毒性。\n72                                                                                                                                                                                              所以我们进一步研究了不同形式的热刺激对原代T细胞的影响（见附录图3）。\n73                                                                                                                                                                                                                        我们发现，热刺激时间越长，死亡的细胞越多。\n74                                                                                                       但是通过聚焦超声技术，其脉冲产生的热刺激能够减少细胞毒性的产生，同时有效诱导基因的表达，且产生和总加热时间相同且持续热刺激的细胞组一样的效果（见附录图3）。\n75                         且在总加热时间15分钟，实际脉冲热刺激占空比50%，即时间对半的情况下（见附录图3中的a，方案2），聚焦超声技术仍有效诱导了91.4%的eGFP增强型绿色荧光蛋白的表达，且造成的细胞毒性极小，热刺激后24小时测得细胞存活率为92.2%（见附录图3中的b到d）。\n76                                                                                                                                                                                   我们将上述热刺激形式（见附录图3中的a，方案2）进一步应用到肿瘤体内治疗的研究中。\n77                                                                                                                                                                                                利用磁共振成像引导聚焦超声诱导基因激活的仿真体模型模拟和体内实验。\n78                                                                                                                                                            磁共振成像引导的聚焦超声能将热能限制在体内的目标点位内，且因其拥有高时空分辨率，微观变化可以清晰捕捉。\n79                                                                                                                                                                          我们结合7T磁共振成像，一种最高端的磁共振成像和聚焦超声系统进行实验，详细见技术原理部分。\n80                                                                                                                                                                我们将环形阵列换能器放置到磁共振成像的孔腔中，正对仿真体模型以及小鼠目标点位上方，为了提高精准度。\n81                                                                                                                                                                                         获取磁共振图像，上传至名为Thermoguide的软件中，以获得目标点位的实时温度。\n82                                                                                             实时温度将反馈到比例-积分-微分控制系统，该系统使实际温度同设定温度一致，以实现自动调节聚焦超声的输出功率，使目标点位的温度能够维持在设定水平（见图3中的a和附录图4）。\n83   随后，我们将Nalm-6肿瘤细胞的基因转导给靠慢病毒载体表达的双荧光素酶报告基因，该基因携带可诱导的Fluc萤火虫荧光素酶以及必需的Rluc海肾荧光素酶（如图3中的b所示，基因排序为：Hsp热休克蛋白启动因子–Fluc萤火虫荧光素酶–PGK酶–Rluc海肾荧光素酶–红色荧光染料mCherry）。\n84                                                                                                                                                                                  随后，我们将处理好的细胞注入自制的豆腐仿真体模型中（见图3中的c和技术原理部分）。\n85                                                                                                                                                                                                                        上下调节焦距，使超声波作用于注入的细胞上。\n86                                                                                                              超声刺激8小时后，通过细胞中的Fluc萤火虫荧光素酶与Rluc海肾荧光素酶比值可知，三次长达5分钟的聚焦超声大大诱导了基因的表达（见图3中的d和技术原理部分）。\n87                                                                                                                                   当同样对细胞进行三次长达5分钟的热刺激，超声的诱导效果同使用热循环仪的阳性对照组一致，阳性对照组的结果是预料中的（见图3中的d）。\n88                                                                                                                                                                                          这证实了该方法可以高效地通过超声波基因表达技术调控改造细胞中的基因激活。\n89                                                                              我们随后通过磁共振成像引导的聚焦超声控制小鼠体内目标点位的温度（见图3中的e及f，和附录视频2），并通过带有双荧光素酶报告基因的Nalm-6肿瘤细胞在小鼠体内检测聚焦超声激活的基因表达情况。\n90                              结果显示，同一般情况下的对照组，即未注入细胞前，通过聚焦超声刺激目标点位和未经聚焦超声刺激的对照组相比，两次长达5分钟的聚焦超声刺激，大大诱导了注入细胞的基因表达（实验组在注入细胞后，通过聚焦超声刺激目标点位）（见图3中的g和h）。\n91                                                                                                                                                                                                         体内实验之改造后的CAR-T细胞经聚焦超声诱导后产生细胞毒性。\n92                                                                                             为了在体内检测可聚焦超声诱导的CAR-T细胞的细胞毒性，我们在NSG免疫缺陷小鼠的两侧，皮下注射了携带Fluc萤火虫荧光素酶的 Nalm-6肿瘤细胞，从而形成对称的肿瘤（见图4中的a）。\n93                                                                                                                四天后，在两侧肿瘤注射区域皮下注入经改造后的含CD19抗体的CAR-T细胞，但仅对左侧肿瘤加以三次长达5分钟的聚焦超声刺激，将温度维持在43°C（见图4中的a）。\n94                                                                                                                                    结果显示，同右侧肿瘤相比，左侧肿瘤的生长明显受到了抑制，从而揭示了经聚焦超声诱导的CAR-T细胞在体内的细胞毒性（见图4中的b和c）。\n95                                                                                                                                             我们还设置了一个对照组，只在小鼠的一侧肿瘤处用聚焦超声加以刺激，但均不注入T细胞到小鼠两侧的肿瘤处（见附录图5中的a）。\n96                                                                                                                                              对照组小鼠两侧肿瘤的生长曲线相似，证明三次长达5分钟的聚焦超声本身几乎不对肿瘤生长产生抑制作用（见附录图5中的b和c）。\n97                                                                                                                                  另一个对照组中，小鼠两侧的肿瘤处注入了原代T细胞，仅对左侧肿瘤加以聚焦超声刺激，发现小鼠两侧肿瘤的生长曲线同样相似（见附录图6）。\n98                                                                                                                                                               所以，我们的结果表明，聚焦超声可以用于精确调控体内可聚焦超声诱导的CAR-T细胞对目标肿瘤细胞的杀伤性。\n99                                                                                                                                                               为了进一步验证该方法的有效性，我们针对进一步分化的肿瘤，检测可聚焦超声诱导的CAR-T细胞对其的杀伤性。\n100                                                                                                                                            我们在NSG免疫缺陷小鼠的左侧皮下注入带有Fluc萤火虫荧光素酶的Nalm-6肿瘤细胞，从而形成单个肿瘤，并以此作为模型进行实验。\n101                                                                                                                                                                      肿瘤细胞注入十天后，我们在肿瘤注射区域注入可聚焦超声诱导的CAR-T细胞，并用聚焦超声将其激活。\n102                                                                                                                                                                                  对照组的肿瘤侧，则注入原代T细胞，随后同样用聚焦超声加以刺激（见补充数据图1a）。\n103                                                                                                 与对照组相比，可聚焦超声诱导的CAR-T细胞显著抑制了肿瘤的生长，证实了聚焦超声诱导的CAR-T细胞疗法能够有效治疗病变时间较长，体积较大的肿瘤（见补充数据图1b至图1d）。\n104                                                                                                                                                                  我们还测试了这种超声波基因表达技术在调控可诱导的CAR-T细胞对其他类型的肿瘤，尤其是实体瘤的效果。\n105                                                                                                                                                                          我们将人的前列腺癌细胞PC3进行改造，使其表达前列腺特异性膜抗原PSMA和Fluc萤火虫荧光素酶。\n106                                                                                                                                            我们还对原代T细胞进行了改造，加入Cre-lox基因开关控制可聚焦超声诱导的抗前列腺特异性膜抗原的CAR（见补充数据图2a和2b）。\n107                                                                                                                                          通过体外共同培养检测细胞毒性和细胞因子，来证明可聚焦超声诱导的前列腺特异性膜抗原CAR-T细胞的作用（见补充数据图2c和2e）。\n108                                                                                                                                                           我们在NSG免疫缺陷小鼠两侧皮下注入前列腺癌细胞PC3，该细胞携带前列腺特异性膜抗原以及Fluc萤火虫荧光素酶。\n109                                                                                                                                                                              五天后，在小鼠两侧肿瘤注射区域皮下注入可聚焦超声诱导的前列腺特异性膜抗原CAR-T细胞。\n110                                                                                                                                                                                                            用三次长达5分钟的聚焦超声刺激左侧肿瘤，右侧不做处理。\n111                                                                                                                                                                              实验结果再一次证明，同对照组相比经过聚焦超声刺激的肿瘤明显受到抑制（见图4中d和e）。\n112                                                                                                                  在监测肿瘤生长的最后一天（实验第22天，聚焦超声处理后的第17天），我们采集了肿瘤组织（详细见技术原理部分），并对引导蛋白质合成的信使RNA进行计数。\n113                                                                              在聚焦超声刺激过的肿瘤中，信使RNA中CD3（T淋巴细胞的标志）的平均数量是对照组的三倍，表明聚焦超声刺激过的实体前列腺肿瘤中的T细胞进一步扩增且出现大量T细胞聚集现象（见附录图7中的a）。\n114                                                                              在受聚焦超声刺激的肿瘤中，经Cre基因开关调控重组的CAR-信使RNA的数量是对照组的9倍，这揭示了受聚焦超声诱导的DNA重组和注入肿瘤处改造的T细胞中CAR的表达情况（见附录图7和技术原理部分）。\n115                                                                                                                   在另一个模拟对照实验中，小鼠两侧的前列腺肿瘤处注入了原代T细胞，但仅对左侧肿瘤进行聚焦超声刺激，结果显示两侧肿瘤生长并无明显差异（见附录图8）。\n116                                                                                                                                  这些实验结果证明了基于聚焦超声的超声波基因表达技术有效调控CAR-T细胞，可用于体内肿瘤疗法且针对各种不同的肿瘤，包括前列腺实体瘤。\n117                                                                                                                                                                                                                            聚焦超声诱导的CAR-T细胞疗法的安全性。\n118                                                                                                                                                                            为了证实聚焦超声诱导的CAR-T细胞的非肿瘤靶向毒性低于一般的CAR-T细胞，且能稳定表达CAR。\n119                                                                                                         我们采用先前的双侧Nalm-6肿瘤模型，一侧视为近端肿瘤，注入含CD19抗体的CAR-T细胞，一侧注入等量但可聚焦超声诱导的CD19 CAR-T细胞（见附录图9和技术原理部分）。\n120                                                                                                                                                                             远端肿瘤用于模拟正常组织，其同样表达目标抗原，将不作任何处理（见附录图10中的a和b）。\n121                                                                                                                                                          一般的CAR-T细胞不仅消灭了近端肿瘤，还攻击了模拟正常组织的远端肿瘤（见图5中的a和b，以及附录图10中的c）。\n122                                                                                                                                      但是聚焦超声诱导的CAR-T细胞在受聚焦超声激活后，显著抑制了近端肿瘤的生长，但避开了远端的肿瘤（见图5的c，d和附录图10中的d）。\n123                                                                                                           在监测肿瘤生长的最后一天，我们参照对照组小鼠的肿瘤生长情况，以计算出一般CAR-T细胞以及受聚焦超声诱导的CAR-T细胞在体内的细胞毒性（详细见技术原理部分）。\n124                                                                                                                                                                                                             对照组小鼠两侧的肿瘤处未注入T细胞（见补充数据图3）。\n125                                                                                                 一般的CAR-T细胞对近端和远端肿瘤的杀伤性分别为100%和99.8%，聚焦超声诱导的CAR-T细胞对近端肿瘤同样有效，杀伤性达95.7%，但对远端肿瘤的杀伤性仅为9.8%（见图5中的e）。\n126                                                                                                                                                    与一般的CAR-T细胞疗法相比，聚焦超声诱导的CAR-T细胞疗法可以说是更加安全，且大大降低了T细胞攻击正常细胞的几率。\n127                                                                                                                                                                                                      聚焦超声诱导的CAR-T细胞的培养，以应用于临床和实现可逆表达。\n128                                                                                                                                                                                                     为了临床应用，我们尽可能减少了操作过程中所需的外部技术支撑。\n129                                                                                  在聚焦超声诱导的CAR-T细胞中，用Hsp热休克蛋白启动因子调控CAR的表达，无需Cre-lox基因开关，且用PGK酶调控红色荧光染料mCherry的表达，揭示基因传递效率（见图6中的a和附录图11中的a）。\n130 聚焦超声诱导的CAR-T细胞能够可逆表达，其CAR受Hsp热休克蛋白调控：第一次热刺激（加热到43°C，时长15分钟）6小时后，原代受Hsp热休克蛋白调控的CAR-T细胞中平均43.9％的CAR发生了表达；12小时后，表达率降至10.5％；24小时后，降至与对照组相同的基准水平（见图6中的b和c）。\n131                                                                                                   第二次热刺激（加热到43°C，时长15分钟）后，平均44.2％的CAR发生了表达，随后CAR的表达率同样下降到基准水平（见图6中的c），这表明受Hsp热休克蛋白调控的CAR是可逆的。\n132                                                                                                                   通过先前实验提到的细胞毒性检测验证聚焦超声诱导的CAR-T细胞的表达，结果显示受热激活的聚焦超声诱导的CAR-T细胞具有更强的细胞杀伤性（见图6中的d）。\n133                                                                                     当效应细胞和靶细胞的比例为1：5时，激活的可逆的聚焦超声诱导的CAR-T细胞与对照组T细胞产生的毒性相差最大，前者消灭了83％的肿瘤细胞，对照组仅消灭了36％的肿瘤细胞（见图6中的d）。\n134                                                                                                                                                                                              我们通过细胞产生的细胞因子数衡量T细胞的定向杀伤程度（见图6中的e）。\n135                                                                                                                                           为了探究可逆的聚焦超声诱导的CAR-T细胞在体内的表现，我们让NSG免疫缺陷小鼠的两侧长出带有Fluc萤火虫荧光素酶的Nalm-6肿瘤。\n136                                                                                                                     一侧肿瘤，视为近端肿瘤处注入可逆的聚焦超声诱导的CAR-T细胞并用聚焦超声激活，在第4天和第7天再次用聚焦超声刺激肿瘤注入区域（见附录图11中的b）。\n137                                                                                                                                                                                                                         另一侧的肿瘤，视为远端肿瘤，则不做处理。\n138                                                                                                       结果显示，同远端肿瘤相比，近端肿瘤的生长明显受到了抑制（见图6中的f和g），表明可逆的聚焦超声诱导的CAR-T细胞不仅能够有效抑制肿瘤的生长，还将副作用降到最低。\n139                                                                                                                                                                                        对照组中，近端肿瘤在第4天和第7天分别再次用聚焦超声处理，但并未注入T细胞。\n140                                                                                                                                                    我们发现，近端肿瘤同远端肿瘤一样对正常细胞产生攻击，说明聚焦超声的反复刺激不会抑制肿瘤生长（见补充数据图4）。\n141                                                                                                                                            另一对照组的近端肿瘤在第4天和第7天接受了可逆的聚焦超声诱导的CAR-T细胞的注射，但并未用聚焦超声处理（见补充数据图5a）。\n142                                                                                  我们发现虽然近端肿瘤的生长略有减缓，由于CAR本身会发生表达，T细胞也可能产生同种异体反应，排斥注入的人的外来细胞，但在第24天，肿瘤还是平均增长了1,318倍（见补充数据图5b，和5c）。\n143                                                                                                                                              我们的这些结果，验证了可逆的聚焦超声诱导的CAR-T细胞可以逆转自身的表达，且更加安全，无需大量未经临床测试的外部技术。\n```\n:::\n:::\n\n\n## Data Preparation\n\n### Acquisition\n\n*  Read files\n\n\n::: {.cell}\n\n```{.r .cell-code}\n# Load packages\nlibrary(readr)      # writing and reading data\nlibrary(dplyr)      # manipulating data\nlibrary(fs)         # interacting with file system\nlibrary(stringr)    # match words \nlibrary(qtalrkit)   # using`data_origin`\nlibrary(knitr)      # for `kable()` function\nlibrary(kableExtra) # creating formatted tables\n\nCAR_ST_lines <-\n  read_lines(\"data/original/CAR_ST.txt\") # reading the text by lines\n\nfile_cn <- \"data/original/CAR_TT.txt\"\n\nEncoding(file_cn) <- \"UTF-8\"\n\nCAR_TT_lines <-\n  read_lines(file_cn) # reading the text by lines\n```\n:::\n\n\n*  Write files into `.csv`.\n\n\n::: {.cell}\n\n```{.r .cell-code}\nCAR_ST_lines_df <-\n  tibble(\n  type = \"Source\",\n  lines = CAR_ST_lines\n  ) |> mutate (\n  sentence_id = row_number()\n  )\n\nCAR_TT_lines_df <-\n  tibble(\n  type = \"Target\",\n  lines = CAR_TT_lines\n  ) |> mutate (\n  sentence_id = row_number()\n  )\n\nif(!file.exists(\"data/original/CAR_ST.csv\")){\n  write_csv(CAR_ST_lines_df,\n  file = \"data/original/CAR_ST.csv\")}\n\nif(!file.exists(\"data/original/CAR_TT.csv\")){write_csv(CAR_TT_lines_df,\n  file = \"data/original/CAR_TT.csv\")}\n```\n:::\n\n\n### Curation\n\n*  Tidy\n\n\n::: {.cell}\n\n```{.r .cell-code}\nCAR_ST_lines_df <-\n  CAR_ST_lines_df |>\n  select(\n  sentence_id,\n  type,\n  lines\n  )\n\nCAR_TT_lines_df <-\n  CAR_TT_lines_df |>\n  select(\n  sentence_id,\n  type,\n  lines\n  )\n```\n:::\n\n\n### Transformation\n\n1. **Read files**\n\n\n::: {.cell}\n\n```{.r .cell-code}\nST_df <-\n  read_csv(\"data/derived/CAR_ST_curated.csv\")\n\nTT_df <-\n  read_csv(\"data/derived/CAR_TT_curated.csv\")\n```\n:::\n\n\n2. **Counting metadiscourse markers**\n\na. hedges\n\n*  For English hedges' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nhedg_may_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Mm]ay\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_typ_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Tt]ypically\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_rel_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Rr]elatively\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_sli_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]lightly\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_pro_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Pp]robably\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_sug_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]uggest.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nhedges_num_EN = hedg_may_num + hedg_typ_num + hedg_rel_num + hedg_sli_num + hedg_pro_num + hedg_sug_num\n```\n:::\n\n\n*  For Mandarin hedges' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nhedg_yi_num <- \n  TT_df |>\n filter(str_detect(lines, \".*一定程度.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_ke_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\可能.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_ji_num <- \n  TT_df |>\n filter(str_detect(lines, \".*几乎.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_ky_num <- \n  TT_df |>\n filter(str_detect(lines, \".*可以说是.*\")) |>\n  summarise(num_sentences = n())\n\nhedg_l_num <- \n  TT_df |>\n filter(str_detect(lines, \".*略有.*\")) |>\n  summarise(num_sentences = n())\n\nhedges_num_CN = hedg_yi_num + hedg_ke_num + hedg_ji_num + hedg_ky_num + hedg_l_num\n```\n:::\n\n\nb. boosters\n\n*  For English boosters' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nbo_es_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ee]specially\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_su_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]ubstantially\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_si_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]ignificantly\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_dr_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Dd]ramatically\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_pr_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Pp]recisely\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_me_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Mm]erely\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_pa_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Pp]articularly\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_in_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ii]n\\\\s*particular\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_ve_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Vv]ery\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_wi_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ww]ithout\\\\s*any\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_de_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Dd]emonstrate.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_ind_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ii]ndicate.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nbo_ver_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Vv]erif.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nboosters_num_EN = bo_es_num + bo_su_num + bo_si_num +bo_dr_num + bo_pr_num + bo_me_num + bo_pa_num + bo_in_num + bo_ve_num + bo_wi_num + bo_de_num + bo_ind_num + bo_ver_num\n```\n:::\n\n\n*  For Mandarin boosters' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nbo_bh_num <- \n  TT_df |>\n filter(str_detect(lines, \".*不会.*\")) |>\n  summarise(num_sentences = n())\n\nbo_wf_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\无法.*\")) |>\n  summarise(num_sentences = n())\n\nbo_bz_num <- \n  TT_df |>\n filter(str_detect(lines, \".*不再.*\")) |>\n  summarise(num_sentences = n())\n\nbo_wx_num <- \n  TT_df |>\n filter(str_detect(lines, \".*无需.*\")) |>\n  summarise(num_sentences = n())\n\nbo_bd_num <- \n  TT_df |>\n filter(str_detect(lines, \".*不对.*\")) |>\n  summarise(num_sentences = n())\n\nbo_jb_num <- \n  TT_df |>\n filter(str_detect(lines, \".*均不.*\")) |>\n  summarise(num_sentences = n())\n\nbo_gs_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\更是.*\")) |>\n  summarise(num_sentences = n())\n\nbo_bx_num <- \n  TT_df |>\n filter(str_detect(lines, \".*必需.*\")) |>\n  summarise(num_sentences = n())\n\nbo_jn_num <- \n  TT_df |>\n filter(str_detect(lines, \".*就能.*\")) |>\n  summarise(num_sentences = n())\n\nbo_rh_num <- \n  TT_df |>\n filter(str_detect(lines, \".*任何.*\")) |>\n  summarise(num_sentences = n())\n\nbo_dd_num <- \n  TT_df |>\n filter(str_detect(lines, \".*大大.*\")) |>\n  summarise(num_sentences = n())\n\nbo_yq_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\尤其.*\")) |>\n  summarise(num_sentences = n())\n\nbo_zy_num <- \n  TT_df |>\n filter(str_detect(lines, \".*只有.*\")) |>\n  summarise(num_sentences = n())\n\nbo_j_num <- \n  TT_df |>\n filter(str_detect(lines, \".*仅.*\")) |>\n  summarise(num_sentences = n())\n\nbo_z_num <- \n  TT_df |>\n filter(str_detect(lines, \".*最.*\")) |>\n  summarise(num_sentences = n())\n\nbo_ji_num <- \n  TT_df |>\n filter(str_detect(lines, \".*极.*\")) |>\n  summarise(num_sentences = n())\n\nbo_mx_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\明显.*\")) |>\n  summarise(num_sentences = n())\n\nbo_xz_num <- \n  TT_df |>\n filter(str_detect(lines, \".*显著.*\")) |>\n  summarise(num_sentences = n())\n\nbo_zs_num <- \n  TT_df |>\n filter(str_detect(lines, \".*证实.*\")) |>\n  summarise(num_sentences = n())\n\nbo_js_num <- \n  TT_df |>\n filter(str_detect(lines, \".*揭示.*\")) |>\n  summarise(num_sentences = n())\n\nbo_zm_num <- \n  TT_df |>\n filter(str_detect(lines, \".*证明.*\")) |>\n  summarise(num_sentences = n())\n\nbo_yz_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\验证.*\")) |>\n  summarise(num_sentences = n())\n\nbo_bcz_num <- \n  TT_df |>\n filter(str_detect(lines, \".*不存在.*\")) |>\n  summarise(num_sentences = n())\n\nboosters_num_CN = bo_bh_num + bo_wf_num + bo_bz_num + bo_wx_num + bo_bd_num + bo_jb_num + bo_gs_num + bo_bx_num + bo_jn_num + bo_rh_num + bo_dd_num + bo_yq_num + bo_zy_num + bo_j_num + bo_z_num + bo_ji_num + bo_mx_num + bo_zs_num + bo_js_num + bo_zm_num + bo_yz_num + bo_bcz_num\n```\n:::\n\n\nc. attitude markers\n\n*  For English attitude markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\natt_dif_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Dd]ifficult\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\natt_sig_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]ignificant\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nattitude_num_EN = att_dif_num + att_sig_num\n```\n:::\n\n\n*  For Mandarin attitude markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\natt_yw_num <- \n  TT_df |>\n filter(str_detect(lines, \".*有望.*\")) |>\n  summarise(num_sentences = n())\n\natt_n_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\难.*\")) |>\n  summarise(num_sentences = n())\n\nattitude_num_CN = att_yw_num + att_n_num\n```\n:::\n\n\nd. engagement markers\n\n*  For English engagement markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\neng_gi_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Gg]iven\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nengagement_num_EN = eng_gi_num\n```\n:::\n\n\n*  For Mandarin engagement markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\neng_sm_num <- \n  TT_df |>\n filter(str_detect(lines, \".*说明.*\")) |>\n  summarise(num_sentences = n())\n\nengagement_num_CN = eng_sm_num\n```\n:::\n\n\ne. self-mentions\n\n*  For English self-mentions' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nsel_we_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ww]e\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nsel_ou_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Oo]ur\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nself_num_EN = sel_we_num + sel_ou_num\n```\n:::\n\n\n*  For Mandarin self-mentions' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nsel_wm_num <- \n  TT_df |>\n filter(str_detect(lines, \".*我们.*\")) |>\n  summarise(num_sentences = n())\n\nself_num_CN = sel_wm_num\n```\n:::\n\n\nf. transitions\n\n*  For English transitions' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\ntr_ho_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Hh]owever\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_wh_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ww]hile\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_bu_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Bb]ut\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_thu_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Tt]hus\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_in_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ii]n\\\\s*contrast(?:\\\\sto)?\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_ad_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Aa]dditionally\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_mo_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Mm]oreover\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_al_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Aa]lso\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_st_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ss]till\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_the_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Tt]herefore\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_as_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Aa]s\\\\s*such\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntr_an_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Aa]nd\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ntransitions_num_EN = tr_ho_num + tr_wh_num + tr_bu_num + tr_thu_num + tr_in_num + tr_ad_num + tr_mo_num + tr_al_num + tr_st_num + tr_the_num + tr_as_num + tr_an_num \n```\n:::\n\n\n*  For Mandarin transitions' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\ntr_d_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\但.*\")) |>\n  summarise(num_sentences = n())\n\ntr_re_num <- \n  TT_df |>\n filter(str_detect(lines, \".*然而.*\")) |>\n  summarise(num_sentences = n())\n\ntr_e_num <- \n  TT_df |>\n filter(str_detect(lines, \".*而.*\")) |>\n  summarise(num_sentences = n())\n\ntr_sr_num <- \n  TT_df |>\n filter(str_detect(lines, \".*虽然.*\")) |>\n  summarise(num_sentences = n())\n\ntr_ds_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\但是.*\")) |>\n  summarise(num_sentences = n())\n\ntr_q_num <- \n  TT_df |>\n filter(str_detect(lines, \".*且.*\")) |>\n  summarise(num_sentences = n())\n\ntr_ce_num <- \n  TT_df |>\n filter(str_detect(lines, \".*从而.*\")) |>\n  summarise(num_sentences = n())\n\ntr_rc_num <- \n  TT_df |>\n filter(str_detect(lines, \".*如此.*\")) |>\n  summarise(num_sentences = n())\n\ntr_yy_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\由于.*\")) |>\n  summarise(num_sentences = n())\n\ntr_zy_num <- \n  TT_df |>\n filter(str_detect(lines, \".*这样一来.*\")) |>\n  summarise(num_sentences = n())\n\ntr_yw_num <- \n  TT_df |>\n filter(str_detect(lines, \".*因为.*\")) |>\n  summarise(num_sentences = n())\n\ntr_sy_num <- \n  TT_df |>\n filter(str_detect(lines, \".*所以.*\")) |>\n  summarise(num_sentences = n())\n\ntr_yc_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\因此.*\")) |>\n  summarise(num_sentences = n())\n\ntr_sh_num <- \n  TT_df |>\n filter(str_detect(lines, \".*随后.*\")) |>\n  summarise(num_sentences = n())\n\ntr_rg_num <- \n  TT_df |>\n filter(str_detect(lines, \".*如果.*\")) |>\n  summarise(num_sentences = n())\n\ntr_r_num <- \n  TT_df |>\n filter(str_detect(lines, \".*若.*\")) |>\n  summarise(num_sentences = n())\n\ntr_h_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\或.*\")) |>\n  summarise(num_sentences = n())\n\ntr_ts_num <- \n  TT_df |>\n filter(str_detect(lines, \".*同时.*\")) |>\n  summarise(num_sentences = n())\n\ntr_yj_num <- \n  TT_df |>\n filter(str_detect(lines, \".*以及.*\")) |>\n  summarise(num_sentences = n())\n\ntr_ren_num <- \n  TT_df |>\n filter(str_detect(lines, \".*仍.*\")) |>\n  summarise(num_sentences = n())\n\ntr_he_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\和.*\")) |>\n  summarise(num_sentences = n())\n\ntr_y_num <- \n  TT_df |>\n filter(str_detect(lines, \".*也.*\")) |>\n  summarise(num_sentences = n())\n\ntr_xb_num <- \n  TT_df |>\n filter(str_detect(lines, \".*相比.*\")) |>\n  summarise(num_sentences = n())\n\ntr_bin_num <- \n  TT_df |>\n filter(str_detect(lines, \".*并.*\")) |>\n  summarise(num_sentences = n())\n\ntransitions_num_CN = tr_d_num + tr_re_num + tr_e_num + tr_sr_num + tr_ds_num + tr_q_num + tr_ce_num + tr_rc_num + tr_yy_num + tr_zy_num + tr_yw_num + tr_sy_num + tr_yc_num + tr_sh_num + tr_rg_num + tr_r_num + tr_h_num + tr_ts_num + tr_yj_num + tr_ren_num + tr_he_num + tr_y_num + tr_xb_num + tr_bin_num\n```\n:::\n\n\ng. frame markers\n\n*  For English frame markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nfr_fi_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ff]irst.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nfr_th_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Tt]hen\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nfr_fu_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ff]urther\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nfr_re_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Rr]ecently\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nfr_he_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Hh]ere\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nfr_ta_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Tt]aken\\\\s*together\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nframe_num_EN = fr_fi_num + fr_th_num +fr_fu_num + fr_re_num + fr_he_num + fr_ta_num\n```\n:::\n\n\n*  For Mandarin frame markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nfr_sx_num <- \n  TT_df |>\n filter(str_detect(lines, \".*首先.*\")) |>\n  summarise(num_sentences = n())\n\nfr_xs_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\先是.*\")) |>\n  summarise(num_sentences = n())\n\nfr_dc_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\第.次.*\")) |>\n  summarise(num_sentences = n())\n\nfr_zs_num <- \n  TT_df |>\n filter(str_detect(lines, \".*这是.*\")) |>\n  summarise(num_sentences = n())\n\nfr_db_num <- \n  TT_df |>\n filter(str_detect(lines, \".*第.部分.*\")) |>\n  summarise(num_sentences = n())\n\nfr_jb_num <- \n  TT_df |>\n filter(str_detect(lines, \".*进一步.*\")) |>\n  summarise(num_sentences = n())\n\nframe_num_CN = fr_sx_num + fr_xs_num + fr_dc_num + fr_zs_num + fr_db_num + fr_jb_num\n```\n:::\n\n\nh. endophoric markers\n\n*  For English endophoric markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nend_fi_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ff]ig\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nend_vi_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Vv]ideo\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nend_me_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\bMethods\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nend_as_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Aa]s\\\\s*describe.*\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nendophoric_num_EN = end_fi_num + end_vi_num + end_me_num + end_as_num\n```\n:::\n\n\n*  For Mandarin endophoric markers' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nend_jt_num <- \n  TT_df |>\n filter(str_detect(lines, \".*见图.*\")) |>\n  summarise(num_sentences = n())\n\nend_ru_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\如图.*\")) |>\n  summarise(num_sentences = n())\n\nend_bc_num <- \n  TT_df |>\n filter(str_detect(lines, \".*补充数据图.*\")) |>\n  summarise(num_sentences = n())\n\nend_flt_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\附录图.*\")) |>\n  summarise(num_sentences = n())\n\nend_js_num <- \n  TT_df |>\n filter(str_detect(lines, \".*技术原理部分.*\")) |>\n  summarise(num_sentences = n())\n\nend_fa_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\方案.*\")) |>\n  summarise(num_sentences = n())\n\nend_sp_num <- \n  TT_df |>\n filter(str_detect(lines, \".*附录视频.*\")) |>\n  summarise(num_sentences = n())\n\nend_ss_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\上述.*\")) |>\n  summarise(num_sentences = n())\n\nend_xq_num <- \n  TT_df |>\n filter(str_detect(lines, \".*先前.*\")) |>\n  summarise(num_sentences = n())\n\nendophoric_num_CN = end_jt_num + end_ru_num + end_bc_num + end_flt_num + end_js_num + end_fa_num + end_sp_num + end_ss_num + end_xq_num\n```\n:::\n\n\ni. code glosses\n\n*  For English code glosses' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nco_fo_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ff]or\\\\s*instance\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\nco_in_num <- \n  ST_df |>\n filter(str_detect(lines, \".*\\\\b[Ii]ncluding\\\\b.*\")) |>\n  summarise(num_sentences = n())\n\ncode_num_EN = co_fo_num + co_in_num\n```\n:::\n\n\n*  For Mandarin code glosses' number\n\n\n::: {.cell}\n\n```{.r .cell-code}\nco_j_num <- \n  TT_df |>\n filter(str_detect(lines, \".*即.*\")) |>\n  summarise(num_sentences = n())\n\nco_g_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\该.*\")) |>\n  summarise(num_sentences = n())\n\nco_qz_num <- \n  TT_df |>\n filter(str_detect(lines, \".*其中.*\")) |>\n  summarise(num_sentences = n())\n\nco_bk_num <- \n  TT_df |>\n filter(str_detect(lines, \".*\\\\包括.*\")) |>\n  summarise(num_sentences = n())\n\ncode_num_CN = co_j_num + co_g_num + co_qz_num + co_bk_num\n```\n:::\n\n\n3. **Metadiscourse marker tibble**\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_tbl <- tibble(\n  Category = c(\"hedges\", \"boosters\",  \"attitude markers\", \"engagement markers\", \"self-mentions\", \"transitions\", \"frame markers\", \"endophoric markers\", \"code glosses\"),\n  Num_EN = c(as.numeric(hedges_num_EN), as.numeric(boosters_num_EN),  as.numeric(attitude_num_EN), as.numeric(engagement_num_EN), as.numeric(self_num_EN), as.numeric(transitions_num_EN), as.numeric(frame_num_EN), as.numeric(endophoric_num_EN), as.numeric(code_num_EN)),\n  Num_CN = c(as.numeric(hedges_num_CN), as.numeric(boosters_num_CN), as.numeric(attitude_num_CN), as.numeric(engagement_num_CN), as.numeric(self_num_CN), as.numeric(transitions_num_CN), as.numeric(frame_num_CN), as.numeric(endophoric_num_CN), as.numeric(code_num_CN))\n) \n```\n:::\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n```\n            Category Num_EN Num_CN\n1             hedges      9      7\n2           boosters     29     65\n3   attitude markers      4      5\n4 engagement markers      1      1\n5      self-mentions     43     44\n6        transitions     95    165\n7      frame markers     18     13\n8 endophoric markers     70     83\n9       code glosses      2     23\n```\n:::\n:::\n\n\n## Data Analysis\n\nBased on my inquiry, `Is the number of metadiscourse markers greater in the target text than in the source text?`, my analysis is focused on inferential analysis and univariate analysis by comparing the mean. With a dataset transformed to contain the number of metadiscourse markers in both the source and target texts, I plan to compare them by category to calculate the `p-value` and `confidence interval`. The null hypothesis posits that there is no difference in metadiscourse markers between the target and source texts. The alternative hypothesis is that the number of metadiscourse markers in the target text is greater  than ones in the source text. \n\n### Load packages\n\n\n::: {.cell}\n\n```{.r .cell-code}\n# Load packages\nlibrary(tidytext)     # text manipulation\nlibrary(ggplot2)      # plotting\nlibrary(infer)      # for statistical inference\nlibrary(skimr)      # for descriptive statistics\nlibrary(janitor)    # for cross-tabulation\n```\n:::\n\n\n### Read files\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_inf_tbl <-\n  read_csv(\"data/derived/meta_inf.csv\")\n\nmeta__inf_tbl <-\n  meta_inf_tbl |> \n  mutate(Category = factor(Category))|>\n  mutate(Text_type = factor(Text_type))\n\nmeta_inf_tbl \n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 18 × 4\n   Category_id Category           Text_type   Num\n         <dbl> <chr>              <chr>     <dbl>\n 1           1 hedges             ST            9\n 2           2 boosters           ST           29\n 3           3 attitude markers   ST            4\n 4           4 engagement markers ST            1\n 5           5 self-mentions      ST           43\n 6           6 transitions        ST           95\n 7           7 frame markers      ST           18\n 8           8 endophoric markers ST           70\n 9           9 code glosses       ST            2\n10          10 hedges             TT            7\n11          11 boosters           TT           65\n12          12 attitude markers   TT            5\n13          13 engagement markers TT            1\n14          14 self-mentions      TT           44\n15          15 transitions        TT          165\n16          16 frame markers      TT           13\n17          17 endophoric markers TT           83\n18          18 code glosses       TT           23\n```\n:::\n:::\n\n\n### Identify\n\n\n::: {.cell}\n\n```{.r .cell-code}\n# Dataset\nmeta_inf_tbl \n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 18 × 4\n   Category_id Category           Text_type   Num\n         <dbl> <chr>              <chr>     <dbl>\n 1           1 hedges             ST            9\n 2           2 boosters           ST           29\n 3           3 attitude markers   ST            4\n 4           4 engagement markers ST            1\n 5           5 self-mentions      ST           43\n 6           6 transitions        ST           95\n 7           7 frame markers      ST           18\n 8           8 endophoric markers ST           70\n 9           9 code glosses       ST            2\n10          10 hedges             TT            7\n11          11 boosters           TT           65\n12          12 attitude markers   TT            5\n13          13 engagement markers TT            1\n14          14 self-mentions      TT           44\n15          15 transitions        TT          165\n16          16 frame markers      TT           13\n17          17 endophoric markers TT           83\n18          18 code glosses       TT           23\n```\n:::\n\n```{.r .cell-code}\n# Specify the relationship\nmeta_spec <-\n  meta__inf_tbl |>\n  specify(Num ~ Text_type)\n\n# Preview\nmeta_spec\n```\n\n::: {.cell-output .cell-output-stdout}\n```\nResponse: Num (numeric)\nExplanatory: Text_type (factor)\n# A tibble: 18 × 2\n     Num Text_type\n   <dbl> <fct>    \n 1     9 ST       \n 2    29 ST       \n 3     4 ST       \n 4     1 ST       \n 5    43 ST       \n 6    95 ST       \n 7    18 ST       \n 8    70 ST       \n 9     2 ST       \n10     7 TT       \n11    65 TT       \n12     5 TT       \n13     1 TT       \n14    44 TT       \n15   165 TT       \n16    13 TT       \n17    83 TT       \n18    23 TT       \n```\n:::\n:::\n\n\n### Inspect\n\n\n::: {.cell}\n\n```{.r .cell-code}\n# Density plot\nmeta_inf_tbl |>\n  ggplot(aes(x = Num, fill = Text_type)) +\n  geom_density(alpha = 0.75) +\n  labs(\n  x = \"Metadiscourse markers number\",\n  y = \"Density\",\n  fill = \"Text type\"\n  )\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/assess-distribution-1.png){width=672}\n:::\n\n```{.r .cell-code}\nmeta__inf_tbl |>\n  ggplot(aes(x = Text_type, y = Num, fill = Text_type)) +\n  geom_boxplot(notch = TRUE) +\n  labs(\n  x = \"Text type\",\n  y = \"Metadiscourse markers number\",\n  fill = \"Text type\"\n  )\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/assess-distribution-2.png){width=672}\n:::\n\n```{.r .cell-code}\nggplot(meta__inf_tbl, aes(x = Num, color = Text_type)) +\n  stat_ecdf() +\n  labs(\n  x = \"Metadiscourse markers number\",\n  y = \"ECDF\",\n  color = \"Text type\"\n  )\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/assess-distribution-3.png){width=672}\n:::\n:::\n\n\n### Interrogate\n\n#### Observed statistic\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_obs <-\n  meta_spec |>\n  # Target Text - Source Text\n  calculate(stat = \"diff in means\", order = c(\"TT\", \"ST\"))\n\nmeta_obs\n```\n\n::: {.cell-output .cell-output-stdout}\n```\nResponse: Num (numeric)\nExplanatory: Text_type (factor)\n# A tibble: 1 × 1\n   stat\n  <dbl>\n1    15\n```\n:::\n:::\n\n\n#### Null distribution\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_null <-\n  meta_spec |>\n  hypothesize(null = \"independence\") |>\n  generate(reps = 1000, type = \"permute\") |>\n  calculate(stat = \"diff in means\", order = c(\"TT\", \"ST\"))\n\nmeta_null |> visualize() +\n  shade_p_value(obs_stat = meta_obs, direction = \"greater\")\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/generate-null-distribution-1.png){width=672}\n:::\n:::\n\n\n#### P-value\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_p <-\n  meta_null |>\n  get_p_value(obs_stat = meta_obs, direction = \"greater\")\n\nmeta_p\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 1 × 1\n  p_value\n    <dbl>\n1   0.259\n```\n:::\n:::\n\n\n#### Resampling distribution\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_boot <-\n  meta_spec |>\n  generate(reps = 1000, type = \"bootstrap\") |>\n  calculate(stat = \"diff in means\", order = c(\"TT\", \"ST\"))\n\nmeta_boot |> visualize()\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/generate-resampling-distribution-1.png){width=672}\n:::\n:::\n\n\n#### Confidence interval\n\n\n::: {.cell}\n\n```{.r .cell-code}\nmeta_ci <-\n  meta_boot |>\n  get_confidence_interval(level = 0.95)\n\nmeta_ci\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 1 × 2\n  lower_ci upper_ci\n     <dbl>    <dbl>\n1    -22.4     58.8\n```\n:::\n:::\n\n\n### Interpret\n\n\n::: {.cell}\n\n```{.r .cell-code}\n# Evaluate the p-value\nmeta_p\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 1 × 1\n  p_value\n    <dbl>\n1   0.259\n```\n:::\n\n```{.r .cell-code}\n# Evaluate the confidence interval\nmeta_ci\n```\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 1 × 2\n  lower_ci upper_ci\n     <dbl>    <dbl>\n1    -22.4     58.8\n```\n:::\n\n```{.r .cell-code}\nmeta_boot |>\n  visualize() +\n  shade_confidence_interval(meta_ci)\n```\n\n::: {.cell-output-display}\n![](prospectus_files/figure-html/evaluate-1.png){width=672}\n:::\n:::\n\n\n# Expected results\n\nThere is no difference in metadiscourse markers between the target and source texts.\n\n# Communication plan\n\nFor the public, I created a PowerPoint presentation and slideshows in Quarto using `reveal.js`. It contains the elements of `intro`, `literature review`, `research question`, `methods`, `findings`. Since I'm presenting to individuals outside my field, I explain the meaning of terminologies specific to our field. To share with peers, I push my repository to GitHub with `renv.lock` and `README` to ensure reproducibility. The final result is in HTML format.\n\n# Conclusion\n\nThe translation methods we recommended did not significantly assist the comprehension of the target readers. However, it's important to note that this conclusion is based on a small dataset. Further testing with larger corpora or collaboration with target readers to gather feedback could provide more insights into the effectiveness of the translation methods. In addition, future researchers targetting on biomedical literature translation could explore alternative perspectives to enhance comprehension for the target audience.\n\n# References\n\n::: {#refs}\n:::\n\n# Appendix {.appendix}\n\n![Hyland's Metadiscourse Model](meta.png)\n\n![Hyland's Metadiscourse Model in Chinese](meta_CN.png)\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 49 × 2\n   Category EN_Word      \n   <chr>    <chr>        \n 1 hedges   may          \n 2 hedges   probably     \n 3 hedges   slightly     \n 4 hedges   relatively   \n 5 hedges   suggest      \n 6 hedges   typically    \n 7 boosters especially   \n 8 boosters substantially\n 9 boosters dramatically \n10 boosters significantly\n# ℹ 39 more rows\n```\n:::\n\n::: {.cell-output .cell-output-stdout}\n```\n# A tibble: 75 × 2\n   Category CN_Word \n   <chr>    <chr>   \n 1 hedges   可能    \n 2 hedges   几乎    \n 3 hedges   略有    \n 4 hedges   一定程度\n 5 hedges   可以说是\n 6 boosters 尤其    \n 7 boosters 大大    \n 8 boosters 明显    \n 9 boosters 显著    \n10 boosters 仅      \n# ℹ 65 more rows\n```\n:::\n:::\n",
    "supporting": [
      "prospectus_files/figure-html"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}